<乌鸦传媒>PD-1 Inhibitor Falls Short in Triple-Negative Breast Cancer No survival benefit with pembrolizumab vs chemotherapy in second-, third-line treatment Mar 08, 2021
<乌鸦传媒>New Targeted Therapies Show Promise in Cancer Selected abstracts from the ESMO Targeted Anticancer Therapies virtual meeting Mar 03, 2021
<乌鸦传媒>Mammo Study: One Saves Lives, More Exams Save More Lives Risk of fatal breast cancer decreases with increasing participation in screening Mar 02, 2021
<乌鸦传媒>FDA Panel Slows the Roll for Pembrolizumab in Breast Cancer Advisory committee: Wait for more data before considering neoadjuvant indication Feb 09, 2021
<乌鸦传媒>Has Pembrolizumab Finally Met an Indication FDA Doesn't Like? Agency staff skeptical of data in early breast cancer Feb 08, 2021
<乌鸦传媒>Optimizing Neoadjuvant Therapy for Breast Cancer ASCO guideline covers patient selection, treatment options, follow-up Feb 02, 2021
<乌鸦传媒>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemo News, features, and commentary about cancer-related issues Jan 21, 2021
<乌鸦传媒>Oncotype DX Misses on Breast Cancer Risk in Black Women Accuracy of 21-gene recurrence score worse compared with white women Jan 21, 2021
<乌鸦传媒>Not Just BRCA: Large Studies ID Other Key Breast Cancer Risk Genes Implications for screening and other risk-management strategies, researchers say Jan 20, 2021
<乌鸦传媒>Most Women Satisfied With 'Going Flat' After Mastectomy Lack of surgeon support key factor in later dissatisfaction, study shows Jan 08, 2021
<乌鸦传媒>PARP Inhibitors Linked With Blood Cancer Risk Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<乌鸦传媒>Add-On HDAC Inhibitor No Help in Breast Cancer PFS, OS similar to endocrine therapy alone for advanced HR+ disease Dec 15, 2020
<乌鸦传媒>Broader Role for PARP Inhibitors in Breast Cancer? Responses in tumors with somatic or germline mutations related to HRD Dec 14, 2020
<乌鸦传媒>Online Tool Refines Individual Risks in Breast Cancer RSClin incorporates 21-gene recurrence score with tumor grade, size, and more Dec 13, 2020
<乌鸦传媒>Doctor-Patient Discord in Reporting Radiation Toxicity Physicians underrecognized substantial symptoms in more than half of patients Dec 11, 2020
<乌鸦传媒>Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancer No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
<乌鸦传媒>Chemotherapy Improved TNBC Survival in Older Women Benefits noted in both node-negative and -positive disease, as well as for those with a comorbidity score greater than 0 Dec 08, 2020
<乌鸦传媒>Study Reassures on MS Patients' Breast, Colorectal Cancer Risk But higher incidence of other cancers in Canadian data Nov 25, 2020
<乌鸦传媒>New Clinical Strategy for HR-Positive Breast Cancer? Ki67 values before, after preop endocrine therapy associated with recurrence risk Nov 17, 2020
<乌鸦传媒>COVID Deaths Drop in the Hospitalized; Miracle Mouthwash? New Organ Discovered A daily roundup of news on COVID-19 and the rest of medicine Oct 21, 2020
<乌鸦传媒>No Benefit With Anti-PD-L1 Drug in Metastatic TNBC Lack of progression-free, overall survival boost with atezolizumab contrast with prior trial Sep 22, 2020
<乌鸦传媒>Adjuvant Anti-CDK Thwarts Early Breast Cancer Recurrence Risk of invasive recurrence declines 25% in patients with high-risk disease Sep 20, 2020
<乌鸦传媒>Newly Approved Drug Boosts Survival in Metastatic TNBC Antibody-drug conjugate as third-line option improved survival, response rates Sep 20, 2020
<乌鸦传媒>Skip Chemo for Older Patients With HER2+ Breast Cancer? Less than one-month survival loss at 3 years with trastuzumab monotherapy Sep 18, 2020
<乌鸦传媒>Double Mastectomy Linked to Sexual, Body Image Issues in Young Women Pre-op counseling or decision aids could help women make better informed decisions Sep 16, 2020
<乌鸦传媒>DCIS Tied to Higher Chance of Breast Cancer Death Black women and those under 40 at particularly high risk Sep 16, 2020
<乌鸦传媒>Which Women Choose Hormones for Surgical Menopause? Understanding patterns of use can help improve targeting for education and counseling, researchers say Aug 12, 2020
<乌鸦传媒>Survival Effect of pCR Elusive in Breast Cancer 80% lower risk of recurrence with surrogate endpoint, but link to survival unproven Jul 23, 2020
<乌鸦传媒>Older Age Should Not Rule Out Chemo in Breast Cancer Patients Providers should consider patient priorities when discussing treatment Jul 17, 2020
<乌鸦传媒>The Serious Conversation: Delivering Bad News by Telemedicine As office visits move online, clinicians discuss breaking life-changing diagnoses virtually Jul 13, 2020
<乌鸦传媒>Brief Quasi-Fasting Diet Boosts Breast Cancer Chemo Response Randomized trial in neoadjuvant setting Jun 28, 2020
<乌鸦传媒>Pembrolizumab May Help in Triple-Negative Breast Cancer Upfront therapy extends progression-free survival in metastatic disease, study shows Jun 01, 2020
<乌鸦传媒>Surgery for Metastatic Breast Cancer Fails to Boost Overall Survival Cumulative data, though, don't rule out benefit for selected patients with de novo stage IV disease Jun 01, 2020
<乌鸦传媒>Add-On Tucatinib Ups Survival in Breast Cancer With Brain Mets TKI plus trastuzumab-capecitabine reduced risk of death by nearly half Jun 01, 2020
<乌鸦传媒>HCQ Linked to Harm in Cancer Patients Combination with azithromycin associated with three-fold risk of mortality, registry study shows May 28, 2020
<乌鸦传媒>End of Life and COVID-19; DCIS Doubles Cancer Risk; Training for 'Bad News' News, features, and commentary about cancer-related issues May 28, 2020
<乌鸦传媒>New Clue to Anti-PD-L1 Activity in Breast Cancer? Survival benefit with durvalumab in patients with PDL1 copy number alteration May 26, 2020
<乌鸦传媒>Five Days of G-CSF Adequate for Breast Cancer Chemo Rate of chemotherapy-induced febrile neutropenia similar to 7- to 10-day regimen May 08, 2020
<乌鸦传媒>Honing Chemo Use in Small Breast Tumors Clearest survival benefit for 8-10 mm tumors in HR/HER2-positive disease May 03, 2020
<乌鸦传媒>Talzenna Misses OS Endpoint in BRCA-Positive Breast Cancer But PARP inhibitor improved patient-reported outcomes over standard therapy Apr 29, 2020
